Jérémie Mortier
Cím
Hivatkozott rá
Hivatkozott rá
Év
The impact of molecular dynamics on drug design: applications for the characterization of ligand–macromolecule complexes
J Mortier, C Rakers, M Bermudez, MS Murgueitio, S Riniker, G Wolber
Drug Discovery Today 20 (6), 686-702, 2015
1292015
Anthocyanin composition, antioxidant efficiency, and α-amylase inhibitor activity of different Hungarian sour cherry varieties (Prunus cerasus L.)
JR Homoki, A Nemes, E Fazekas, G Gyémánt, P Balogh, F Gál, J Al-Asri, ...
Food chemistry 194, 222-229, 2016
592016
NF-κB inducing kinase (NIK) inhibitors: Identification of new scaffolds using virtual screening
J Mortier, B Masereel, C Remouchamps, C Ganeff, J Piette
Bioorganic & medicinal chemistry letters 20 (15), 4515-4520, 2010
512010
Design, synthesis and molecular docking study of novel quinoxalin-2 (1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their …
SA Galal, SHM Khairat, FAF Ragab, AS Abdelsamie, MM Ali, SM Soliman, ...
European journal of medicinal chemistry 86, 122-132, 2014
502014
Synthesis, biological activity and structure–activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in …
R Ottanà, R Maccari, J Mortier, A Caselli, S Amuso, G Camici, A Rotondo, ...
European Journal of Medicinal Chemistry 71, 112-127, 2014
382014
More than a look into a crystal ball: Protein structure elucidation guided by molecular dynamics simulations
M Bermudez, J Mortier, C Rakers, D Sydow, G Wolber
Drug Discovery Today 21 (11), 1799-1805, 2016
362016
Computational tools for in silico fragment-based drug design
J Mortier, C Rakers, R Frederick, G Wolber
Current topics in medicinal chemistry 12 (17), 1935-1943, 2012
362012
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase
C Rakers, SM Schwerdtfeger, J Mortier, S Duwe, T Wolff, G Wolber, ...
Bioorganic & medicinal chemistry letters 24 (17), 4312-4317, 2014
352014
In silico virtual screening approaches for anti-viral drug discovery
MS Murgueitio, M Bermudez, J Mortier, G Wolber
Drug Discovery Today: Technologies 9 (3), e219-e225, 2012
352012
Impact of fluorination on proteolytic stability of peptides: a case study with α-chymotrypsin and pepsin
V Asante, J Mortier, G Wolber, B Koksch
Amino acids 46 (12), 2733-2744, 2014
322014
Design, synthesis and structure–activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor
SA Galal, AS Abdelsamie, SM Soliman, J Mortier, G Wolber, MM Ali, ...
European journal of medicinal chemistry 69, 115-124, 2013
292013
Computational close up on protein–protein interactions: how to unravel the invisible using molecular dynamics simulations?
C Rakers, M Bermudez, BG Keller, J Mortier, G Wolber
Wiley Interdisciplinary Reviews: Computational Molecular Science 5 (5), 345-359, 2015
282015
Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans
CD Cadicamo, J Mortier, G Wolber, M Hell, IE Heinrich, D Michel, ...
Biochemical pharmacology 85 (7), 881-887, 2013
222013
Identification of PPARγ agonists from natural sources using different in silico approaches
RB El-Houri, J Mortier, MS Murgueitio, G Wolber, LP Christensen
Planta Med 81 (6), 488-94, 2015
212015
Tailored presentation of carbohydrates on a coiled coil-based scaffold for asialoglycoprotein receptor targeting
E Zacco, J Hütter, JL Heier, J Mortier, PH Seeberger, B Lepenies, ...
ACS Chemical Biology 10 (9), 2065-2072, 2015
202015
3D-QSAR, design, synthesis and characterization of trisubstituted harmine derivatives with in vitro antiproliferative properties
C Meinguet, C Bruyère, R Frédérick, V Mathieu, C Vancraeynest, ...
European journal of medicinal chemistry 94, 45-55, 2015
202015
Impact of fluorination on proteolytic stability of peptides in human blood plasma
V Asante, J Mortier, H Schlüter, B Koksch
Bioorganic & medicinal chemistry 21 (12), 3542-3546, 2013
202013
Pyrazolo [4, 3-c] isoquinolines as potential inhibitors of NF-κB activation
J Mortier, R Frederick, C Ganeff, C Remouchamps, P Talaga, L Pochet, ...
Biochemical pharmacology 79 (10), 1462-1472, 2010
202010
Truly Target-focused pharmacophore modeling: a novel tool for mapping intermolecular surfaces
J Mortier, P Dhakal, A Volkamer
Molecules 23 (8), 1959, 2018
172018
Arginase structure and inhibition: catalytic site plasticity reveals new modulation possibilities
J Mortier, JRC Prévost, D Sydow, S Teuchert, C Omieczynski, ...
Scientific reports 7 (1), 1-9, 2017
172017
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20